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ASBTRACT 
Due to the presence of biofilms in sewer systems, conventional and trace organic chemicals may 
undergo significant biological transformation during wastewater drainage. Modelling in-sewer 
conversion processes of organic chemicals is thus crucial in view of predicting their occurrence in 
sewers, especially for wastewater-based epidemiology. In this study, biotransformation of two illicit 
drugs, methadone (METD) and its human metabolite EDDP, was assessed in aerobic and anaerobic 
biofilms in two lab-scale annular rotating reactors, simulating typical conditions in sewers. Two 
models were tested to describe biofilm-mediated transformation, namely (i) a model based on the 
Activated Sludge Model for Xenobiotics (ASM-X) framework, and (ii) an extension of ASM-X 
with description of primary metabolic processes based on existing Activated Sludge Models (e.g., 
ASM1). Results indicate that transformation of the selected drugs can only be modelled using the 
second approach, as biotransformation is enhanced in the presence of bioavailable organic carbon.  
 
INTRODUCTION 
Transformation of organic chemicals present in untreated sewage can be significantly influenced by 
sewer biofilms. While pressurized sewers are predominantly anaerobic and favor the growth, among 
others, of sulfate reducing bacteria (SRB), gravity sewers are mostly aerobic due to reaeration and 
heterotrophic biomass prevails in biofilms with comparably high activity (Hvitved-Jacobsen et al. 
2002). Understanding the role of sewer biofilms on the transformation of pollutants can help 
predicting pollutant loadings to downstream wastewater treatment plants. This is even more 
relevant to the emerging field of wastewater-based epidemiology, in which estimation of illicit drug 
consumption at community level relies on the quantification of urinary drug biomarkers in untreated 
wastewater. Recent research has been focusing on illicit drug transformation in sewers (Ramin et 
al., 2016; McCall et al., 2016). To the best of our knowledge, there has been no comprehensive 
study correlating the functionality of in-sewer biofilm on transformation of primary pollutants (e.g., 
organic substrates) and trace organic chemicals (e.g., illicit drugs) under different redox conditions. 
Thus, the aim of this study was to investigate the removal of illicit drugs and primary pollutants 
(COD, sulfate) in well-controlled biofilm systems under aerobic and anaerobic conditions.   
 
MATERIALS AND METHODS 
Experimental assessment  
Two annular rotating biofilm reactors were used to simulate shear conditions prevailing in the 
sewers (see Fig. 1). The reactors were run for 14 months under continuous-flow operation, fed with 
pre-clarified wastewater (4 L d
-1
), to establish stable biofilms (thickness: 0.75 mm, aerobic; 1 mm, 
anaerobic). Batch experiments were then performed by connecting each biofilm reactor to an 
external tank (recirculation flow=4 L h
-1
). Experiments were started by spiking a mixture of 16 
  
illicit drugs and metabolites (final concentration=10 μg L-1) in methanol (MeOH) to the external 
tanks. During the experiments, temperature (aerobic Tmean=17.0°C; anaerobic Tmean=17.8°C) and pH 
(aerobic pHmean=8.7; anaerobic pHmean=9.2) were monitored. Samples were collected to measure 
illicit drug concentrations at regular intervals. Biological activity in the reactors was also monitored 
by measuring soluble COD, nitrate, ammonium and sulfate using colorimetric methods. Batch 
experiments (volume=4 L) to assess sorption to biofilms were carried out by suspending the biofilm 
on two removable slides in tap water and used and adding sodium azide (0.05%) to inhibit 
biological activity. Sample preparation and analysis for drug biomarkers were carried out according 
to Bijlsma et al. (2013). Further details can be also found in Ramin et al. (2016).  
 
Modelling framework  
To simulate biofilm-mediated transformation of drug biomarkers, two 1-D models were tested:  
a) transformation-sorption model based on the Activated Sludge Model for Xenobiotics (ASM-
X) (Plósz et al., 2013), in which biofilm was considered as a homogeneous medium and 
negligible biomass growth was assumed. Biotransformation was described using pseudo-
first-order kinetics (constant biomass). 
b) an extension of the above-mentioned ASM-X, with the description of primary metabolic 
processes as in the Activated Sludge Model no. 1 (ASM1; Henze et al., 2000) for 
heterotrophic and autotrophic biomass and as in Jiang et al. (2009) for anaerobic processes. 
In the latter model, the biofilm was considered as heterogeneous medium, in which biofilm 
growth and detachment were explicitly described. Biotransformation in model was 
formulated using second-order kinetics with active biomass as a state variable and a 
switching function for bioavailable organic carbon (i.e., biotransformation enhancement in 
presence of substrate). 
 
Model parameters for abiotic transformation, sorption and biotransformation by suspended solids  
were adopted from Ramin et al., 2016. Chemical fluxes between bulk phase and biofilm were 
described according to the two-film theory, with no reaction occurring in the boundary layer 
(Wanner et al., 2006). The spatial discretization of the biofilm was done according to Vangsgaard et 
al. (2012). The models were implemented in Matlab R2014a (MathWorks, US). 
 
RESULTS AND DISCUSSION  
Biological activity of reactor  
Concentrations of soluble COD, sulfate, ammonium and nitrate during biofilm experiments are 
presented in Fig. 2. We assumed that methanol (MeOH), introduced with the spiking solution, is not 
utilized as growth substrate, similarly to what found for suspended biomass (Ramin et al., 2016). 
The final soluble COD data reflect the concentration of inert COD and residual (not evaporated) 
MeOH. Sulfate was significantly removed in the anaerobic reactor during the first day of the 
experiment, (likely due to SRB activity), while remaining constant during the second day (possibly 
in the absence of readily biodegradable organic substrate). In the aerobic biofilm, sulfate was 
formed likely due to hydrogen sulfide oxidation. Ammonium removal was shown under both redox 
conditions. In the aerobic reactor, this could have resulted from ammonia assimilation for growth, 
considering that nitrifiers are usually outcompeted by heterotrophs in sewer biofilms (Jiang et al., 
2009). Nevertheless, ammonia stripping may not be excluded at high pH in both reactors.  
 
Sorption and transformation of drug biomarkers 
Fig. 3 illustrates the concentration profiles of two drug biomarkers, methadone (METD) and its 
main human metabolite (EDDP) during batch experiments with active biofilm. It was observed that 
METD is sorbed in both aerobic and anaerobic biofilms whilst EDDP was only sorbed in the 
anaerobic biofilm (data not shown). METD removal was much higher in the aerobic biofilm than in 
  
the anaerobic one. The opposite was observed for EDDP, i.e., higher removal in the anaerobic 
biofilm. It was assumed that these chemicals have independent transformation pathways in biofilms, 
similar to raw wastewater (Ramin et al., 2016). The simplified biofilm model (a) was used to 
simulate the transformations. It was observed that there is a systematic deviation between model 
predictions and measurements (Fig. 3). It can be hypothesized that these chemicals undergo a co-
metabolic transformation with enhancement effect in which the drug transformation rate is reduced 
significantly during the second day of the experiment where readily biodegradable substrate was 
possibly limiting. The preliminary results of model (b) – describing co-metabolic processes in a 
heterogeneous biofilm model – can more precisely predict the removal of the selected drug 
biomarkers (data not shown).  
 
This study demonstrates the capability of sewer biosolids to transform drug biomarkers. 
Furthermore, the study shows the importance of identifying the right model structure (i.e., co-
metabolic model) to properly predict biofilm mediated drug transformation. The model identified 
and calibrated in this study will contribute to increase the accuracy of drug consumption estimates 
in wastewater based epidemiology.    
 
 
Figure 1. Configuration of annular rotating biofilm reactor connected to an external jacketed tank 
with recirculating flow during a batch experiment. Samples were taken from the outlet of the 
biofilm reactor. To maintain aerobic and anaerobic conditions inside the reactors, the external tank 
was sparged with dried atmospheric air or nitrogen, respectively. The profile inside the reactor 
illustrates a typical concentration profile of substrates inside the biofilm.  
 
 
 
Figure 2. Concentrations of soluble COD, sulfate, ammonium and nitrate during biofilm 
experiments in batch mode under aerobic and anaerobic conditions.  
 
 
 
Biofilm Boundary 
layer
Bulk
Rotating biofilm 
reactor 
External jacketed 
tank
Pump
Valve
Soluble COD
Time (h)
0 10 20 30 40
g
C
O
D
m
-3
0
100
200
300
400
500
600
Aerobic biofilm
Anaerobic biofilm
Sulfate
Time (h)
0 10 20 30 40
g
S
m
-3
0
5
10
15
20
25
30
Aerobic biofilm
Anaerobic biofilm
NH4+-N
Time (h)
0 10 20 30 40
g
N
m
-3
20
30
40
50
60
70
NO3--N
Time (h)
0 10 20 30 40
g
N
m
-3
0.0
0.2
0.4
0.6
0.8
Total COD
Time (h)
0 10 20 30 40
g
N
m
-3
100
200
300
400
500
600
Aer bic biofilm
Anaer bic biofilm
Aerobic biofilm
Anaerobic biofilm
Aerobic biofilm
Anaerobic biofilm
  
 
Figure 3. Concentration profiles of METD and EDDP during batch experiments with aerobic and 
anaerobic biofilms. The shaded areas reflect the 95% confidence interval of the model (a) 
predictions.  
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